LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 1 von insgesamt 1

Suchoptionen

Artikel ; Online: Utility of short-interval follow-up mammography after a benign-concordant stereotactic breast biopsy result.

Maldonado, Sean / Gandhi, Nishant / Ha, Tony / Choi, Patrick / Khalkhali, Iraj / Kalantari, Babak N / Dauphine, Christine

Breast (Edinburgh, Scotland)

2018  Band 42, Seite(n) 50–53

Abstract: Background: There is currently no clear consensus recommendation for the use of short-interval follow-up mammography after a benign-concordant breast biopsy (BCBB), and practice patterns vary widely. The objectives of this study were to evaluate whether ...

Abstract Background: There is currently no clear consensus recommendation for the use of short-interval follow-up mammography after a benign-concordant breast biopsy (BCBB), and practice patterns vary widely. The objectives of this study were to evaluate whether a short-interval follow-up mammogram provided clinical utility after stereotactic BCBB and to examine the costs associated with this surveillance strategy.
Methods: A retrospective review of women who underwent a stereotactic breast biopsy yielding benign-concordant results between January 2005 and October 2014 was performed to evaluate findings on subsequent imaging, to calculate compliance with recommended short-interval imaging, and to examine whether subsequent imaging revealed an abnormality at the site of the initial stereotactic BCBB. A cost analysis was performed utilizing Medicare reimbursement rates to calculate projected and actual costs of short-interval follow-up imaging after stereotactic BCBB.
Results: Of the 470 stereotactic BCBB performed, a short-interval mammogram was completed in 207 (44.0%), 9 (4.3%) of which had suspicious mammographic findings at the initial biopsy site, and 6 subsequently underwent biopsy, with none resulting in malignant or high-risk pathology. The cost of short-interval mammographic follow-up (n = 207) was calculated at $28,541.16.
Conclusions: This study provides evidence that 6-month follow-up mammography has low clinical utility and unnecessarily increases costs after stereotactic BCBB. A safe and more cost-effective strategy may be resumption of routine mammography at 12 months post-biopsy.
Mesh-Begriff(e) Adult ; Breast Neoplasms/diagnostic imaging ; Breast Neoplasms/economics ; Breast Neoplasms/pathology ; Breast Neoplasms/surgery ; Early Detection of Cancer/economics ; Early Detection of Cancer/statistics & numerical data ; Female ; Follow-Up Studies ; Humans ; Image-Guided Biopsy/economics ; Image-Guided Biopsy/statistics & numerical data ; Mammography/economics ; Mammography/statistics & numerical data ; Middle Aged ; Neoplasm Staging ; Prognosis ; Retrospective Studies
Sprache Englisch
Erscheinungsdatum 2018-08-23
Erscheinungsland Netherlands
Dokumenttyp Journal Article
ZDB-ID 1143210-x
ISSN 1532-3080 ; 0960-9776
ISSN (online) 1532-3080
ISSN 0960-9776
DOI 10.1016/j.breast.2018.08.101
Signatur
Zs.A 3620: Hefte anzeigen Standort:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)
Zs.MO 588: Hefte anzeigen
Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

Zusatzmaterialien

Kategorien

Zum Seitenanfang